CDH1 and cancer: Throughout EMT, the cancer cells endure frequently molecular events, for instance, a decrease of the level of epithelial markers (E-cadherin, cytokeratins) and an increase of the level of mesenchymal markers (N-cadherin, vimentin) (Figure 3).